Vitamin E As a Potential Interventional Treatment for Metabolic Syndrome: Evidence from Animal and Human Studies - PubMed (original) (raw)

Review

Vitamin E As a Potential Interventional Treatment for Metabolic Syndrome: Evidence from Animal and Human Studies

Sok Kuan Wong et al. Front Pharmacol. 2017.

Abstract

A constellation of medical conditions inclusive of central obesity, hyperglycemia, hypertension, and dyslipidemia is known as metabolic syndrome (MetS). The safest option in curtailing the progression of MetS is through maintaining a healthy lifestyle, which by itself, is a long-term commitment entailing much determination. A combination of pharmacological and non-pharmacological approach, as well as lifestyle modification is a more holistic alternative in the management of MetS. Vitamin E has been revealed to possess anti-oxidative, anti-inflammatory, anti-obesity, anti-hyperglycemic, anti-hypertensive and anti-hypercholesterolemic properties. The pathways regulated by vitamin E are critical in the development of MetS and its components. Therefore, we postulate that vitamin E may exert some health benefits on MetS patients. This review intends to summarize the evidence in animal and human studies on the effects of vitamin E and articulate the contrasting potential of tocopherol (TF) and tocotrienol (T3) in preventing the medical conditions associated with MetS. As a conclusion, this review suggests that vitamin E may be a promising agent for attenuating MetS.

Keywords: dyslipidemia; hyperglycemia; hypertension; metabolic syndrome; obesity; tocopherol; tocotrienol; vitamin E.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Summary of possible hypocholesterolemic and hypercholesterolemic actions of tocopherol and tocotrienol, mediated through activation or inhibition of HMG-CoA reductase activity.

References

    1. Aasheim E. T., Hofso D., Hjelmesaeth J., Birkeland K. I., Bohmer T. (2008). Vitamin status in morbidly obese patients: a cross-sectional study. Am. J. Clin. Nutr. 87, 362–369. - PubMed
    1. Aggarwal B. B., Sundaram C., Prasad S., Kannappan R. (2010). Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases. Biochem. Pharmacol. 80, 1613–1631. 10.1016/j.bcp.2010.07.043 - DOI - PMC - PubMed
    1. Alberti K. G., Eckel R. H., Grundy S. M., Zimmet P. Z., Cleeman J. I., Donato K. A., et al. (2009). Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640–1645. 10.1161/CIRCULATIONAHA.109.192644 - DOI - PubMed
    1. Alcala M., Sanchez-Vera I., Sevillano J., Herrero L., Serra D., Ramos M. P., et al. (2015). Vitamin E reduces adipose tissue fibrosis, inflammation, and oxidative stress and improves metabolic profile in obesity. Obesity (Silver. Spring). 23, 1598–1606. 10.1002/oby.21135 - DOI - PubMed
    1. Allen P. S., Brown A. W., Brown M. M., Hsu W. H., Beitz D. C. (2015). Taurine and vitamin E supplementations have minimal effects on body composition, hepatic lipids, and blood hormone and metabolite concentrations in healthy Sprague Dawley rats. Nutr. Diet. Suppl. 7, 77–85. 10.2147/NDS.S88888 - DOI - PMC - PubMed

Publication types

LinkOut - more resources